<DOC>
	<DOCNO>NCT01713062</DOCNO>
	<brief_summary>The purpose randomise prospective multicenter longterm study evaluate survival rate implant , wear periprosthetic osteolysis highly cross-linked polyethylene without addition Vitamin E ( UHMWPE-XE vs. UHMWPE-X ) Total Hip Arthroplasty .</brief_summary>
	<brief_title>Longterm-Evaluation Vitelene® Against Standard</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Hip</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<criteria>Inclusion : Minimum age : 18 year Maximum age : 75 year Indication cementless THA Approval study participation treatment accord study protocol Physical mental willingness adhere clinical radiological follow Exclusion : Patient able join follow Increased risk anaesthesia accord `` American Society Anesthesiology '' : ASA IV Tumor disease Alcohol drug dependency Permanent cortisone therapy Clinical relevant infection Pregnancy plan pregnancy Previous intervention like adjustmentosteotomy , treatment fracture THA affect side Acute fracture affect hip joint Patients bone quality , doesn´t allow cementless treatment Requirements clinical relevant deformity ( condition preoperation bone fracture , leg length discrepancy &gt; 30 mm , Offsetreduction &gt; 30 mm ) Small acetabular treatment 28 mm head Treatments without use ceramic head Treatments require neck prolonging component</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>